Astera Labs, Inc. $ALAB Stock: Sterling Capital Management LLC Reduces Holdings

Sterling Capital Management LLC cut its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 48.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,944 shares of the company’s stock after selling 2,779 shares during the quarter. Sterling Capital Management LLC’s holdings in Astera Labs were worth $1,048,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. BlackRock Inc. acquired a new stake in Astera Labs during the 2nd quarter worth approximately $6,609,581,000. Atreides Management LP lifted its position in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after buying an additional 1,754,593 shares in the last quarter. Van ECK Associates Corp grew its stake in Astera Labs by 20.0% during the second quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock worth $1,080,980,000 after buying an additional 373,545 shares during the period. Bank of America Corp DE purchased a new stake in Astera Labs during the second quarter worth approximately $1,061,791,000. Finally, Amundi grew its stake in Astera Labs by 77.9% during the first quarter. Amundi now owns 1,880,830 shares of the company’s stock worth $206,139,000 after buying an additional 823,477 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Trading Up 0.9%

NASDAQ ALAB opened at $259.51 on Tuesday. The company’s fifty day simple moving average is $310.76 and its 200-day simple moving average is $252.11. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The stock has a market cap of $45.02 billion, a P/E ratio of 128.47 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts expect that Astera Labs, Inc. will post 2.71 EPS for the current fiscal year.

Insider Activity

In other Astera Labs news, Director Stefan Dyckerhoff sold 8,994 shares of the business’s stock in a transaction on Wednesday, October 7th. The shares were sold at an average price of $376.06, for a total value of $3,382,283.64. Following the transaction, the director owned 2,648 shares in the company, valued at $995,806.88. The trade was a 77.25% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 408,558 shares of company stock worth $127,306,034 over the last three months. 10.40% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of brokerages have recently commented on ALAB. UBS Group reissued a “neutral” rating and issued a $425.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. Royal Bank Of Canada upped their price target on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Needham & Company LLC upped their price target on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Weiss Ratings downgraded Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a report on Friday. Finally, TD Cowen cut their price objective on Astera Labs from $375.00 to $300.00 and set a “hold” rating on the stock in a research report on Monday, October 19th. Eleven equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and a consensus target price of $340.79.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.